Chronic condition

Telemedicine Market size is to grow by USD 92.07 billion from 2022 to 2027, North America to account for 41% of market growth - Technavio

Retrieved on: 
Monday, October 2, 2023
COPD, Telehealth, Blockchain, Clinical data management, Diabetes, Service, Telecommunications, Telephone, Health care, USD, Chronic condition, Patient, ROW, Cardiology, Psychiatry, Neurology, Growth, Diagnosis, Research, Health, Telecare, Geography, Medical imaging, Retail, Medical device, Pharmaceutical industry

NEW YORK, Oct. 1, 2023 /PRNewswire/ -- The telemedicine market size is expected to grow by USD 92.07 billion from 2022 to 2027.

Key Points: 
  • NEW YORK, Oct. 1, 2023 /PRNewswire/ -- The telemedicine market size is expected to grow by USD 92.07 billion from 2022 to 2027.
  • North America is estimated to contribute 41% to the growth of the global market during the forecast period.
  • Telemedicine has become an essential component of the region's healthcare landscape, which includes virtual consultations, remote monitoring, and digital health platforms.
  • Growth of the telemedicine market in North America, Europe, Asia, and ROW
    Comprehensive analysis of factors that will challenge the growth of the telemedicine market companies.

NACDD Announces Impact Award Winners and New Board of Directors

Retrieved on: 
Friday, September 29, 2023
BLS, CD, Washington State Department of Labor and Industries, Rising Star Award, Doctor of Public Health, Massachusetts Department of Public Health, Arkansas Department of Health, MSN, Maryland Department of Commerce, Ojamaa, Public, Bureau, Health promotion, Health equity, FNP, Performing arts of Australia, Utah Department of Health, TIME100 Impact Awards, New York State Department of Health, CHES, RDN, Doctor of Philosophy, NCD, DNP, MHS, FAAFP, -elect, Public health, Large, Non-communicable disease, Division, Maryland Department of Health, Family nurse practitioner, Chronic condition, Control, National Association, MPH, Washington State Department of Health, Community health, Pharmaceutical industry, Management, Nursing, MD

ATLANTA, Sept. 29, 2023 /PRNewswire/ -- The National Association of Chronic Disease Directors (NACDD) announced the winners of the 2023 Impact Awards as well as its new Board of Directors during the Annual Business Meeting held Sept. 26.

Key Points: 
  • ATLANTA, Sept. 29, 2023 /PRNewswire/ -- The National Association of Chronic Disease Directors (NACDD) announced the winners of the 2023 Impact Awards as well as its new Board of Directors during the Annual Business Meeting held Sept. 26.
  • The Impact Awards are nominated by NACDD Members and selected by a committee who evaluate the applications to identify the greatest impact on chronic disease prevention and control and health promotion.
  • "The passion, dedication, and innovation shown by NACDD Members across our states and territories is truly inspiring!
  • The newly elected At Large Directors are:
    Victoria Ballares, MSN, DNP, FNP, BLS, a board certified Family Nurse Practitioner in Guam.

Growth Potential in Hemodialysis Vascular Grafts Market Foreseen with Key Trends and Insights (2023-2030) - ResearchAndMarkets.com

Retrieved on: 
Friday, September 29, 2023
Biotechnology, Health, Medical Devices, Well, ESRD, Telehealth, Polytetrafluoroethylene, Vein, COVID-19, Kidney disease, Research, Artery, USD, Government, Dialysis, Incidence, Chronic condition, Patient, Investment, PTFE, Growth, Chronic kidney disease, CKD, Pharmaceutical industry

The global hemodialysis vascular grafts market is set to expand at a CAGR of 5.1% between 2023 and 2030.

Key Points: 
  • The global hemodialysis vascular grafts market is set to expand at a CAGR of 5.1% between 2023 and 2030.
  • COVID-19 catalyzed the adoption of telemedicine, potentially boosting the demand for hemodialysis vascular grafts as more patients gain remote access to treatment.
  • The " Hemodialysis Vascular Grafts Market Size, Share & Trends Analysis Report ," sheds light on the significant potential of the hemodialysis vascular grafts sector.
  • Key Players in the Market:
    Noteworthy companies in the hemodialysis vascular grafts market include:

Clover Health to Host Virtual Clover Assistant Showcase on October 12, 2023

Retrieved on: 
Wednesday, September 20, 2023
Q&A, Health care, Medicare, Clover Health, Patient, Chronic condition, Management, Disease, Nursing, Clover

FRANKLIN, Tenn., Sept. 20, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to bringing access to great healthcare to everyone on Medicare, today announced that it will host a virtual Clover Assistant Showcase on Thursday, October 12, 2023 at 12:00 p.m. Eastern Time.

Key Points: 
  • FRANKLIN, Tenn., Sept. 20, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to bringing access to great healthcare to everyone on Medicare, today announced that it will host a virtual Clover Assistant Showcase on Thursday, October 12, 2023 at 12:00 p.m. Eastern Time.
  • The event will feature informative product demonstrations, followed by a live Q&A session with Clover executives and key members of the Clover Assistant team.
  • "Healthcare is at a pivotal moment, and Clover Assistant is our answer to the challenges we face," said Andrew Toy, Chief Executive Officer of Clover Health.
  • Clover Assistant Anywhere: Streamlining Clinician Workflows through EHR Integrations – hosted by Kevin Holub, Vice President of Product and Design.

Driving Precision Medicine: Rising Demand for Single Cell Analysis Propels Global Market Growth to 2028 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, September 5, 2023
COVID-19, Research, Genetics, Diabetes, Cardiology, Stem Cells, Biotechnology, Health, Science, Oncology, Bio-Rad Laboratories, Prevalence, Investment, SARS-CoV-2, Genomics, Cancer, Single-cell analysis, Medicine, Cell, Danaher Corporation, Competition, Becton, Dickinson and Company headquarters, Huntingdon, Compound annual growth rate, Neuroscience, Promega, NHLBI, HIV disease progression rates, Thermo Fisher Scientific, Application, Chronic condition, Consumables, Flow cytometry, Conditional sentence, Growth, Merck, Mindful Scientific Inc., Safety, Disease, Government, Pharmaceutical industry, Vaccine, Medical imaging, Illumina

The Global Single Cell Analysis Market is expected to experience substantial growth with a steady Compound Annual Growth Rate (CAGR) during the period of 2024 to 2028.

Key Points: 
  • The Global Single Cell Analysis Market is expected to experience substantial growth with a steady Compound Annual Growth Rate (CAGR) during the period of 2024 to 2028.
  • The growth of genomic and proteomic technologies has significantly influenced the expansion of the global single cell analysis market.
  • Chronic diseases, including cancer, cardiovascular conditions, and diabetes, are significant drivers of the global single cell analysis market.
  • Government funding plays a pivotal role in the growth of the global single cell analysis market.

Technological Innovations and Diabetes Prevalence Fueling Growth in the 2023 Global Advanced Wound Care Market

Retrieved on: 
Thursday, August 31, 2023
ScienceDirect, Prevalence, Diabetes, Amputation, Center for Economic Studies (U.S. Census Bureau), Foot, Fatality, Cell, Incidence, United States Census Bureau, Chronic condition, Patient, World Health Organization, Conditional sentence, Growth, Ageing, WHO, Death, Notifiable disease, Wound healing, Nursing, Pharmaceutical industry

The global advanced wound care market is poised for remarkable growth in the upcoming forecast period.

Key Points: 
  • The global advanced wound care market is poised for remarkable growth in the upcoming forecast period.
  • The growing prevalence of chronic diseases is a key driver for the global advanced wound care market.
  • The global advanced wound care market is set to experience significant technological advancements in its products.
  • The prevalence of diabetes globally further stimulates the advanced wound care market.

Huma collaborates with Google Cloud to improve healthcare through generative AI

Retrieved on: 
Tuesday, August 29, 2023
Cloud, Workforce, Burnout, Communication, Partnership, Health, Society for Healthcare Strategy and Market Development, Google Cloud Platform, Biomarker, HCP, Documentation, Vital signs, HIV disease progression rates, Patient, Google Cloud, Chronic condition, Therapy, Medical device, Nursing

Huma and Google Cloud are pursuing the safe, responsible and meaningful integration of generative AI in healthcare

Key Points: 
  • Huma and Google Cloud are pursuing the safe, responsible and meaningful integration of generative AI in healthcare
    NEW YORK, Aug. 29, 2023 /PRNewswire/ -- Huma Therapeutics ("Huma"), a leading global digital health company, today announced it will use Google Cloud's generative AI (GenAI) to enhance Huma's regulated disease management platform.
  • By incorporating AI into its disease management platform, Huma can empower its experts to focus on more complex tasks by automating repetitive ones.
  • Dr Mert Aral, Chief Medical Officer, Huma, said: "Capacity constraints, compounded by staff shortages, continue to be critical challenges across healthcare systems.
  • At the same time, it is paramount that these AI tools are implemented in a responsible and safe manner.

Huma collaborates with Google Cloud to improve healthcare through generative AI

Retrieved on: 
Tuesday, August 29, 2023
Cloud, Workforce, Burnout, Communication, Partnership, Health, Society for Healthcare Strategy and Market Development, Google Cloud Platform, Biomarker, HCP, Documentation, Vital signs, HIV disease progression rates, Patient, Google Cloud, Chronic condition, Therapy, Medical device, Nursing

Huma and Google Cloud are pursuing the safe, responsible and meaningful integration of generative AI in healthcare

Key Points: 
  • Huma and Google Cloud are pursuing the safe, responsible and meaningful integration of generative AI in healthcare
    NEW YORK, Aug. 29, 2023 /PRNewswire/ -- Huma Therapeutics ("Huma"), a leading global digital health company, today announced it will use Google Cloud's generative AI (GenAI) to enhance Huma's regulated disease management platform.
  • By incorporating AI into its disease management platform, Huma can empower its experts to focus on more complex tasks by automating repetitive ones.
  • Dr Mert Aral, Chief Medical Officer, Huma, said: "Capacity constraints, compounded by staff shortages, continue to be critical challenges across healthcare systems.
  • At the same time, it is paramount that these AI tools are implemented in a responsible and safe manner.

Global Artificial Intelligence in Drug Discovery Market Research Report 2023-2028 Featuring Major Players - Atomwise, BenevolentAI, Exscientia, Insilico Medicine, Recursion Pharmaceuticals

Retrieved on: 
Monday, August 28, 2023
Vaccine, Workforce, BioNTech, Drug development, Prevalence, Drug discovery, Cancer, Research, Infection, Government, Acquisition, Patient, Artificial intelligence, SE, Conditional sentence, ESG, AI, Chronic condition, Environment, Medical device, Pharmaceutical industry

DUBLIN, Aug. 28, 2023 /PRNewswire/ -- The "Global Markets for Artificial Intelligence in Drug Discovery" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Aug. 28, 2023 /PRNewswire/ -- The "Global Markets for Artificial Intelligence in Drug Discovery" report has been added to ResearchAndMarkets.com's offering.
  • The current report will provide a detailed overview of the AI in the drug discovery market.
  • Similarly, inorganic strategies amongst market players are also boosting the AI in drug discovery market.
  • Major players in the AI in the drug discovery markets include Atomwise Inc., BenevolentAI, Exscientia, Insilico Medicine, Recursion Pharmaceuticals and many others.

Global Vital Signs Monitoring Devices Market Outlook & Forecast Report 2023: A $33.35+ Billion Industry by 2028 - Patient-Centric Digital Systems and Wearable Devices Drive Growth - ResearchAndMarkets.com

Retrieved on: 
Thursday, August 24, 2023
Medical Devices, Health, Telehealth, Hospital, Disability, Internet of things, Ageing, Quality of life, Electronic health record, Intensive care medicine, Internet, Chronic condition, Vital signs, Developed country, Patient, Risk, Disease, Conditional sentence, Growth, Mortality, RPM, Health information management, Medical device, Health insurance

The "Vital Signs Monitoring Devices Market - Global Outlook & Forecast 2023-2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Vital Signs Monitoring Devices Market - Global Outlook & Forecast 2023-2028" report has been added to ResearchAndMarkets.com's offering.
  • With the advances in technologies in the vital signs monitoring devices market, advanced vital sign devices become more common in various healthcare filed and across daily lives.
  • The increasing demand for remote patient monitoring is accelerating the growth of the vital signs monitoring devices market.
  • The global vital signs monitoring devices market by product is segmented into standalone and integrated vital sign monitoring devices.